'Reliant largely on dwindling supplies from Soviet and American cold war-era stockpiles of precursor radioactive materials, companies have struggled to obtain enough actinium to treat the thousands of patients being enrolled in clinical trials.'

https://www.ft.com/content/6ce668bc-4180-4e84-9feb-f25ac0e83f6f